Worst performer was KIBO:Kibo Mining after a recent rally. These dropped 8%, probably as a result of the PPA not being quite as imminent as everyone expected. However, announcement of a second power generation project should be of long term value.
IQE:IQE dropped 6% in my SIPP and 13% in my ISA so the promised rally caused by closing shorts hasn't happened, even though the shorters are managing to close their positions. Very frustrating!
TLOU:Tlou Energy can't seem to revive after the re-tendering announcement. I thought it had fallen too far at 10p, but this week it dropped another 5% to 8p. At some point soon I'm sure there will be a rebound.
I thought I had purchased VRS:Versarien at just the right time, but I was wrong. A 4% slip this week took them from profit to loss. I never seem to find the bottom when I'm buying.
Thankfully a 2p rise in OPTI:Optibiotix gave me a £1,200 boost, and some 5% rises in RDT:Rosslyn Data and TND:Tandem Group also helped.
SBTX:SkinBioTherapeutics had a great week, climbing 7% but still 37% down, and recent purchase N4P:N4 Pharma also climbed 7% to go 7% into profit.
JLP:Jubilee Metals has had a miserable time lately, but announcement that the Kabwe licence has been re-instated was enough to move the share price up 9%, although a long way to go before being back above water.
Share of the Week is MTFB:Motif Bio which announced the beginning of a staged submission of its NDA this week, along with waiver of the $2m fee. That saw the shares recover by 12% and go back into profit.
It's a very tiny upward-pointing line, but at least it is pointing upwards.
Here's the ISA and share accounts
| Weekly Change | |||
| Cash | £10.36 | +£0 | |
| Portfolio cost | £50,109.65 | +£0 | |
| Portfolio sell value (bid price - commission) | £42.557.43 | (-15.1%) | +£1,004.11 |
| Potential profits | £2,185.00 | -£25.12 | |
| Yr 3 Dividends | £44.15 | +£0 | |
| Yr 3 Profit from sales | £6,246.78 | +£0 | |
| Yr 3 Average monthly cash profit | £795.63 | (18.6%) | -£22.81 |
| Total Dividends | £1,223.20 | +£0 | |
| Total Profit from sales | £12,959.28 | +£0 | |
| Average monthly cash profit | £438.04 | (10.5%) | -£3.17 |
| (Sold stocks profit + Dividends - Fees / Months) |
Potential profits were down slightly thanks to IQE:IQE but £1,004 improvement in value from reduced losses. Not much change elsewhere.
Very tiny tick upwards.
The SIPP looks like this after week 123
| Weekly Change | |||
| Cash | £30.10 | +£0 | |
| Portfolio cost | £27,016.24 | +£0 | |
| Portfolio sell value (bid price - commission) | £26,744.84 | (-1.0%) | +£369.02 |
| Potential profits | £3,471.07 | +£68.78 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £1,023.84 | +£0 | |
| Yr 3 Average monthly cash profit | £224.08 | (10.0%) | -£12.45 |
| Total Dividends | £916.10 | +£0 | |
| Total Profit from sales | £9,949.03 | +£0 | |
| Average monthly cash profit | £376.12 | (16.7%) | -£3.08 |
| (Sold stocks profit + Dividends - Fees / Months) |
The £68 increase in profits is all thanks to N4P:N4 Pharma, as IQE:IQE and CAML:Central Asia Metals both had small losses this week.
Not quite back in the black.
The trading account looks like this after week 89
| Weekly Change | |||
| Cash | £0.03 | +£0 | |
| Portfolio cost | £345.65 | +£0 | |
| Portfolio sell value (bid price - commission) | £150.65 | (-56.4%) | -£11.09 |
| Potential profits | £0 | +£0 | |
| Year 2 Dividends | £0 | +£0 | |
| Year 2 Profit | -£218.50 | +£0 | |
| Yr 2 Average monthly cash profit | -£25.59 | (-88.8%) | +£0.71 |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£241.35 | +£0 | |
| Average monthly cash profit | -£11.70 | (-40.6%) | +£0.13 |
| (Sold stocks profit + Dividends - Fees / Months) |
Oh dear. The yo-yo effect has stopped, and it's heading down.
My optimism was short lived. I fear this portfolio may be doomed!
Next week has one key event - the CAML:Central Asia Metals results. How much will the new purchase have added to profits and what will the dividend be? There may be a price rise leading up to the results, but that risks a big drop on the day. I think I'd rather it stayed at this price and then has a little spurt on the day.
No plans to sell or buy anything for a while now, so it's a waiting game.
No comments:
Post a Comment